V. Bryan Lawlis, Ph.D.
Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee
V. Bryan Lawlis, Ph.D., has served as a director of Geron since March 2012.
He also serves as a member of the boards of directors of BioMarin Pharmaceutical, Inc. since June 2007; Coherus BioSciences, Inc. since May 2014; Aeglea BioTherapeutics, Inc. since July 2018; and several privately-held biotechnology companies. In addition, he serves as an advisor to Phoenix Venture Partners since October 2015. Dr. Lawlis previously served as a director of KaloBios Pharmaceuticals, Inc. from August 2013 to September 2014; and Sutro Biopharma, Inc. from January 2004 to June 2019.
Dr. Lawlis was the President and Chief Executive Officer of Itero Biopharmaceuticals LLC that he co-founded from 2006 to 2011. Dr. Lawlis also held several senior management positions in the biopharmaceutical industry, including President and Chief Executive Officer of Aradigm Corporation and President and Chief Executive Officer of Covance Biotechnology Services which he co-founded. Dr. Lawlis holds a B.A. in microbiology from the University of Texas at Austin and a Ph.D. in biochemistry from Washington State University.